CONCLUSION: HCQ use was associated with lower fasting glucose in women with SLE or RA and also lower (log)HOMA-IR in the SLE group. The use of HCQ may be beneficial for reducing cardiovascular risk by improving glycemic control in these patients.
PMID: 20436082 [PubMed - as supplied by publisher] (Source: J Rheumatol)

More...